2009Journal watchRequires access

Long-Acting Bronchodilators With or Without Inhaled Steroids in COPD

Allan S. Brett

Open publisher page 0 citations

Abstract

Long-acting β-agonists (e.g., salmeterol, formoterol) or anticholinergics (e.g., tiotropium) are recommended initially for patients with chronic obstructive pulmonary disease who have persistent symptoms and require bronchodilator therapy. The addition of inhaled corticosteroids is recommended for patients with repeated exacerbations. In …

About this research paper

What this paper is about

Long-acting β-agonists (e.g., salmeterol, formoterol) or anticholinergics (e.g., tiotropium) are recommended initially for patients with chronic obstructive pulmonary disease who have persistent symptoms and require bronchodilator therapy. The addition of inhaled corticosteroids is recommended for patients with repeated exacerbations. In …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Long-acting β-agonists (e.g., salmeterol, formoterol) or anticholinergics (e.g., tiotropium) are recommended initially for patients with chronic obstructive pulmonary disease who have persistent symptoms and require bronchodilator therapy. The addition of inhaled corticosteroids is recommended for patients with repeated exacerbations. In …

Key concepts: Salmeterol, Medicine, Bronchodilator, Formoterol, COPD, Bronchodilator Agents, Tiotropium bromide, Pulmonary disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Long-Acting Bronchodilators With or Without Inhaled Steroids in COPD — Research Paper | ScholarLens